Table 1.
Patient demographics
| n (%) | |
|---|---|
| Age | |
| <60 years | 10 (41.7) |
| >60 years | 14 (58.3) |
|
| |
| Sex | |
| Female | 16 (66.7) |
| Male | 8 (33.3) |
|
| |
| First intervention | |
| DEB-TACE | 13 (54.2) |
| Y90 | 6 (25.0) |
| Ablation | 5 (20.8) |
|
| |
| Extrahepatic disease | |
| Yes | 15 (62.5) |
| No | 9 (37.5) |
|
| |
| Survival status | |
| Dead | 17 (70.8) |
| Alive | 7 (29.2) |
|
| |
| Prior chemotherapy | |
| Yes | 19 (79.2) |
| No | 5 (20.8) |
|
| |
| ECOG score | |
| 0 | 16 (66.7) |
| 1 | 8 (33.3) |
|
| |
| Lobar disease | |
| Bilobar | 20 (83.3) |
| Unilobar | 4 (16.7) |
|
| |
| Hepatic lesions | |
| Multiple | 20 (83.3) |
| Solitary | 4 (16.7) |
|
| |
| Primary disease site | |
| Retroperitoneum | 8 (33.3) |
| Pelvis | 5 (20.8) |
| Extremities | 5 (20.8) |
| Mesentery | 2 (8.3) |
| IVC | 2 (8.3) |
| Head/Neck | 1 (4.2) |
| Unknown | 1 (4.2) |
DEB-TACE, doxorubicin eluting bead transarterial chemoembolization; Y90, yttrium 90; ECOG, Eastern Cooperative Oncology Group; IVC, inferior vena cava.